STOCK TITAN

Incyte to Present at Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Incyte (Nasdaq: INCY) has announced its upcoming participation at Citi's 2024 Global Healthcare Conference. The presentation is scheduled for Tuesday, December 3, 2024, at 3:15 p.m. in Miami. Investors and interested parties can access the live webcast through Investor.Incyte.com, and a replay will remain available for 30 days following the presentation.

Incyte (Nasdaq: INCY) ha annunciato la sua prossima partecipazione alla Conferenza Globale sulla Sanità 2024 di Citi. La presentazione è programmata per martedì 3 dicembre 2024, alle 15:15 a Miami. Gli investitori e le parti interessate possono accedere alla diretta streaming tramite Investor.Incyte.com, e una registrazione rimarrà disponibile per 30 giorni dopo la presentazione.

Incyte (Nasdaq: INCY) ha anunciado su próxima participación en la Conferencia Global de Salud 2024 de Citi. La presentación está programada para el martes 3 de diciembre de 2024, a las 3:15 p.m. en Miami. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de Investor.Incyte.com, y una grabación estará disponible durante 30 días después de la presentación.

Incyte (Nasdaq: INCY)는 Citi의 2024 글로벌 헬스케어 컨퍼런스에 참여할 예정임을 발표했습니다. 발표는 2024년 12월 3일 화요일 오후 3시 15분에 마이애미에서 예정되어 있습니다. 투자자 및 관심 있는 분들은 Investor.Incyte.com를 통해 생중계를 시청할 수 있으며, 발표 후 30일 동안 다시 보기 서비스가 제공됩니다.

Incyte (Nasdaq: INCY) a annoncé sa prochaine participation à la Conférence Mondiale sur la Santé 2024 de Citi. La présentation est prévue pour le mardi 3 décembre 2024, à 15h15 à Miami. Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct via Investor.Incyte.com, et une rediffusion sera disponible pendant 30 jours après la présentation.

Incyte (Nasdaq: INCY) hat seine bevorstehende Teilnahme an der Citi's Global Healthcare Conference 2024 angekündigt. Die Präsentation ist für Dienstag, den 3. Dezember 2024, um 15:15 Uhr in Miami angesetzt. Investoren und Interessierte können die Live-Übertragung über Investor.Incyte.com abrufen, und eine Wiederholung wird 30 Tage nach der Präsentation zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at Citi’s 2024 Global Healthcare Conference on Tuesday, December 3, 2024 at 3:15 p.m. in Miami.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Media

media@incyte.com

Investors

ir@incyte.com

Source: Incyte

FAQ

When is Incyte (INCY) presenting at Citi's 2024 Global Healthcare Conference?

Incyte (INCY) will present at Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024, at 3:15 p.m. in Miami.

How can I watch Incyte's (INCY) presentation at the Citi Healthcare Conference 2024?

The presentation can be accessed through a live webcast at Investor.Incyte.com, and a replay will be available for 30 days afterward.

Where is Incyte's (INCY) 2024 Citi Global Healthcare Conference presentation taking place?

The presentation will take place in Miami.

How long will Incyte's (INCY) Citi Conference presentation replay be available?

The presentation replay will be available for 30 days following the event.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.72B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON